Evidence map›Paper›PMID 21613224›Full record

ArticleThe Journal of biological chemistry2011

Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.

Sergei A Novgorodov, Bill X Wu, Tatyana I Gudz, Jacek Bielawski, Tatiana V Ovchinnikova, Yusuf A Hannun, Lina M Obeid

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 100 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Sphingolipids in mitochondria-from function to disease.Frontiers in cell and developmental biology · 2023
    Review
  10. The Role of Ceramide in Inherited Retinal Disease Pathology.Advances in experimental medicine and biology · 2023
    Article
  11. Contribution of specific ceramides to obesity-associated metabolic diseases.Cellular and molecular life sciences : CMLS · 2022
    Review
  12. Review
  13. Ceramides and Acute Kidney Injury.Seminars in nephrology · 2022
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. The aetiology and molecular landscape of insulin resistance.Nature reviews. Molecular cell biology · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Sergei A NovgorodovRalph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29401, USA.
Bill X Wu
Tatyana I Gudz
Jacek Bielawski
Tatiana V Ovchinnikova
Yusuf A Hannun
Lina M Obeid
Russian Academy of Sciences · RUInstitute of Bioorganic Chemistry · RUMedical University of South Carolina · USRalph H. Johnson VA Medical Center · US

Funding

THE ROLE OF LACTOSYLCERAMIDE IN RENAL AGING AND DISEASEP20RR017677 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROSSON, CRAIG E. · 2002 to 2011
$23.4M
SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE (SCTR)UL1RR029882 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$10.1M
CERAMIDE ACTIVATED PROTEIN PHOSPHATASESR01CA087584 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HANNUN, YUSUF AWNI · 2000 to 2015
$4.2M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR018823 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2003 to 2003
$2.9M
Mitochondrial Ceramide in Chemotherapy-induced ApoptosisR01AG016583 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OBEID, LINA M · 1998 to 2010
$2.7M
NCI NIH HHS CA87584NCI NIH HHS R01 CA087584NCRR NIH HHS C06 RR018823NCRR NIH HHS P20 RR017677NCRR NIH HHS P20RR17677-04NCRR NIH HHS UL1 RR029882NIA NIH HHS AG16583NIA NIH HHS R01 AG016583
6 · The paper itself

Abstract

Reports suggest that excessive ceramide accumulation in mitochondria is required to initiate the intrinsic apoptotic pathway and subsequent cell death, but how ceramide accumulates is unclear. Here we report that liver mitochondria exhibit ceramide formation from sphingosine and palmitoyl-CoA and from sphingosine and palmitate. Importantly, this activity was markedly decreased in liver from neutral ceramidase (NCDase)-deficient mice. Moreover, the levels of ceramide were dissimilar in liver mitochondria of WT and NCDase KO mice. These results suggest that NCDase is a key participant of ceramide formation in liver mitochondria. We also report that highly purified liver mitochondria have ceramidase, reverse ceramidase, and thioesterase activities. Increased accessibility of palmitoyl-CoA to the mitochondrial matrix with the pore-forming peptide zervamicin IIB resulted in 2-fold increases in palmitoyl-CoA hydrolysis by thioesterase. This increased hydrolysis was accompanied by an increase in ceramide formation, demonstrating that both outer membrane and matrix localized thioesterases can regulate ceramide formation. Also, ceramide formation might occur both in the outer mitochondrial membrane and in the mitochondrial matrix, suggesting the existence of distinct ceramide pools. Taken together, these results suggest that the reverse activity of NCDase contributes to sphingolipid homeostasis in this organelle in vivo.

Indexed as

AnimalsCeramidesHydrolysisLipid MetabolismMaleMiceMice, KnockoutMitochondria, LiverMitochondrial ProteinsNeutral CeramidasePalmitoyl-CoA HydrolasePalmitoyl Coenzyme APeptaibolsRatsRats, Sprague-DawleySphingosineCeramidesMitochondrial ProteinsNeutral CeramidasePalmitoyl-CoA HydrolasePalmitoyl Coenzyme APeptaibolsSphingosinezervamicin IIB

Identifiers

PMID21613224
PMCPMC3137106
OpenAlexW1990834174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.